Editorial
 NEW DPCO & ENFORCEMENT   
 Wednesday, May 22, 2013 
 Department of Pharmaceuticals came out with a notification last week replacing the Drug Price Control Order of 1995 with a new DPCO bringing formulations of 348 drugs under price control. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]R-Tech Ueno begins patient enrollment in phase I/II study of RU-101 ophthalmic solution in US to treat severe dry eye
17:15  [IST]Ranbaxy taking steps to improve quality assurance standards
17:10  [IST]Quintiles rated as leader among CROs in service quality of phase II/III studies
17:00  [IST]Elcelyx begins patient enrolment in phase IIb trial of NewMet for type 2 diabetes
16:00  [IST]Acorda gets additional US patent for Ampyra covering range of dosage strengths
15:00  [IST]AB Science begins phase III trial of masitinib for treatment of Alzheimer's disease
more news >>
TOP NEWS
08:00  [IST]After 2 decades of revival efforts, rehabilitation of IDPL yet to be commenced
08:00  [IST]Pharmacy colleges fear India’s dispensing image may get tarnished, object amendment of Rule 65(15)(c)
08:00  [IST]FIPO urges health ministry to enforce rules to comply with proper storage conditions in pharmacies
08:00  [IST]APDCA seizes drugs worth of Rs.1.5 cr in different cases during past 6 months
08:00  [IST]India, Switzerland to strengthen cooperation in health sector
08:00  [IST]PCI urges health ministry not to amend Rule 65(15)(c) as demanded by trade associations
more news >>
YESTERDAY'S NEWS
18:00  [IST]Takeda, Lundbeck present results from studies with vortioxetine for treatment of MDD at APA meeting
17:00  [IST]US FDA grants breakthrough therapy designation to Synageva's sebelipase alfa to treat early onset LAL deficiency
16:00  [IST]Pfizer discontinues phase III study of inotuzumab ozogamicin in relapsed or refractory aggressive NHL due to futility
15:00  [IST]IMS Health acquires Arizona-based 360 Vantage
14:30  [IST]DIA gears up for 6th regulatory conference at Ahmedabad on May 23 & 24, 2013
14:00  [IST]World Health Assembly opens 66th Sessions to discuss major health issues
more news >>
INTERVIEW  
Industry dynamics such as patent cliff will impact companies differently: Rajiv Malik
rajiv_malik.jpgRajiv Malik, president, Mylan Inc.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the industry support the health ministry's directive to state licensing authorities to grant manufacturing licences in generic names only?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |